For the quarter ending 2026-03-31, XERS has $392,013K in assets. $379,002K in debts. $111,750K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 111,750 | 111,042 | 91,598 | 59,285 |
| Trade accounts receivable, net | 56,295 | 51,050 | 53,751 | 53,048 |
| Inventory, net | 74,234 | 68,673 | 67,462 | 67,282 |
| Prepaid expenses and other current assets | 9,403 | 9,548 | 11,206 | 5,963 |
| Total current assets | 251,682 | 240,313 | 224,017 | 185,578 |
| Property and equipment, net | 5,033 | 4,945 | 4,946 | 5,284 |
| Operating lease right-of-use assets | 21,949 | 22,112 | 22,263 | 22,403 |
| Goodwill | 22,859 | 22,859 | 22,859 | 22,859 |
| Intangible Assets Net Excluding Goodwill | 85,368 | 88,078 | 90,789 | 93,500 |
| Other Assets Noncurrent | 5,122 | 5,220 | 5,317 | 5,062 |
| Total assets | 392,013 | 383,527 | 370,191 | 334,686 |
| Current portion of long-term debt | - | 0 | 0 | 0 |
| Accounts payable | 11,467 | 3,076 | 6,527 | 9,462 |
| Current operating lease liabilities | 6,271 | 6,232 | 6,194 | 6,156 |
| Other accrued liabilities | 32,287 | 33,155 | 30,350 | 24,969 |
| Accrued trade discounts and rebates | 45,492 | 43,253 | 51,264 | 33,169 |
| Accrued returns reserve | 18,723 | 18,969 | 19,216 | 19,782 |
| Other current liabilities | 4,353 | 4,889 | 2,649 | 1,633 |
| Total current liabilities | 118,593 | 109,574 | 116,200 | 95,171 |
| Debt, net of unamortized debt issuance costs, non-current portion | 221,224 | 220,335 | 219,469 | 218,626 |
| Non-current operating lease liabilities | 31,058 | 31,531 | 31,991 | 32,441 |
| Other liabilities | 8,127 | 8,398 | 3,392 | 7,752 |
| Total liabilities | 379,002 | 369,838 | 371,052 | 353,990 |
| Common stockpar value 0.0001, 350,000,000 shares authorized as of march 31, 2026 and december 31, 2025 172,558,783 and 166,215,410 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 18 | 17 | 17 | 16 |
| Additional paid in capital | 682,090 | 685,004 | 681,535 | 663,713 |
| Accumulated deficit | -669,073 | -671,307 | -682,388 | -683,009 |
| Accumulated other comprehensive loss | -24 | -25 | -25 | -24 |
| Total stockholders' equity | 13,011 | 13,689 | -861 | -19,304 |
| Total liabilities and stockholders' equity | 392,013 | 383,527 | 370,191 | 334,686 |
Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings, Inc. (XERS)